Vista Pharma Live Share Price Today, Share Analysis and Chart

Name: Vista Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Vista Pharmaceuticals Ltd.
Rating: 1.37316675
Author: Trendlyne DVM scores

Iran war impact

Based on the analysis of Vista Pharmaceuticals Ltd.'s (VISTAPH) latest financial reports (including the annual report for FY 2024-25 and quarterly results up to December 2025), the impact of the Iran-Israel conflict is minimal to negligible. The ...

7.50 0.12 (1.63%)

42.70% Fall from 52W High

3,226

BSE Volume

BSE 20 Mar, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Not Eligible

Expensive Valuation

- / 100

Technically Neutral

39.8 / 100

No estimates available

Vista Pharma Live Price Chart

Loading Fundamental data..

Loading data..

Is Vista Pharmaceuticals Ltd. worth buying?

18 Votes:

Buy 66.67%

Sell 16.67%

Hold 16.67%

Vista Pharma Live Share Price Today, Share Analysis and Chart

Based on the analysis of Vista Pharmaceuticals Ltd.'s (VISTAPH) latest financial reports (including the annual report for FY 2024-25 and quarterly results up to December 2025), the impact of the Iran-Israel conflict is minimal to negligible. The ...

42.70% Fall from 52W High

SWOT Analysis

Vista Pharma Live Price Chart